1.
Generation of a colony of homozygous K18-hACE2 transgenic mice for the evaluation of vaccine and therapeutic candidates against SARS-CoV-2. FAVET. 2022;20(Suppl.):31-39. doi:10.14409/favecv.v20iSuppl. 11212